Overview

The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.

CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.

At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries.

William J. Clinton Foundation (WJCF) is an Indian not-for-profit entity, registered under Section 8 of the Indian Companies Act 2013, and has an affiliation agreement with the CHAI. Our mission is to save lives and improve health outcomes in the country by enabling the government and private sector to strengthen and sustain quality health systems. WJCF has partnered with the Ministry of Health & Family Welfare and state health departments since 2007, providing technical and operational support across key health priorities, including infectious diseases (COVID-19, hepatitis, HIV, TB, vector-borne diseases), non-communicable diseases (cervical cancer, diabetes, sickle cell disease), maternal and child health (anaemia, immunisation, diarrhoea, pneumonia), sexual and reproductive health, health insurance and digital health (AB PM-JAY, ABDM), oxygen and hypoxemia management, safe drinking water, and climate and health. Learn more about our exciting work: http://www.clintonhealthaccess.org

Program Overview

Lead (Pb) exposure is a silent yet devastating global health crisis, particularly in low- and middle-income countries (LMICs). Research from UNICEF and other partners estimates that 1 in 2 children in LMICs have elevated blood lead levels, contributing neurological damage, reduced cognitive development, and a variety of health impacts.

WJCF is launching a new Lead Exposure Program, building on its proven market shaping capabilities and experience partnering with governments to address large-scale and cross-sectoral health challenges. Likely program priorities include:

• Accelerating adoption of lead-free substitutes, shifting demand to reduce lead exposure, and increasing access to diagnostics and measurement tools.
• Enabling market access for point of care diagnostics.
• Supporting governments to develop and execute strategies to address exposure at both national and sub-national levels.

The program scope is actively being refined in partnership with key stakeholders.

Position Overview

We are seeking a dynamic and analytically rigorous incumbent to support our initiative on reducing lead exposure through two interconnected market interventions: (1) accelerating adoption of lead-free paints and safer substitutes, and (2) shaping markets for point-of-care (POC) lead diagnostics, including identifying and accelerating promising Indian innovations.

This role will lead core research, market analysis, stakeholder engagement, and pilot design efforts translating the supply-chain and market diagnoses into actionable interventions at country and state levels. The incumbent will work across research, strategy, and pilot planning phases, collaborating with governments, raw material suppliers, paint SMEs, diagnostic manufacturers, donors, and technical partners.

The incumbent will report to the Associate Director, New Initiatives.

Position Duration: 5 months (subject to extension)

Location: Delhi-based with domestic travel across Indian states; remote option available

Landscape Analysis & Ideation

Lead-Free Paints & Inputs

• Conduct integrated market assessments of lead-based and lead-free paint and related inputs in India, mapping supply chains of lead-based inputs and lead-free substitutes: input sourcing, manufacturing, distribution, and trade flows.
• Compile and, where possible, triangulate price and trade-flow data; gather distributor and supplier behavior insights.
• Identify key manufacturers of lead chromate and other lead-based pigments and map the landscape of lead-free substitute suppliers.

POC Lead Diagnostics

• Map the current landscape of POC blood lead testing devices available in India, including imported products and domestic manufacturers.
• Identify and assess promising Indian diagnostic innovations at various stages of development, evaluating technical specifications, regulatory status, manufacturing readiness, and cost structures.
• Analyse barriers to scale for diagnostics: pricing, procurement pathways, quality assurance, regulatory approvals, and end-user adoption constraints.

Crosscutting

• Lead Key Informant Interviews (KIIs) with relevant stakeholders (manufacturers, distributors, SMEs, regulators, providers and government bodies) to understand incentives, switching costs, technical constraints, and barriers to adoption.
• Synthesize findings to generate a long list of potential intervention ideas (supply-side, demand-side, regulatory, market shaping) across both paints and diagnostics.

Synthesis & Prioritization

• Apply a structured evaluation framework (unit economics, feasibility, cost–benefit, risk, scenario analysis, scalability) to assess and prioritize intervention ideas from the potential longlist of interventions
• Develop consolidated themes and comparison in collaboration with WJCF Teams and global teams to identify high impact opportunities to meet program goals.
• Produce detailed rationale for selection of a short-list of 3–5 pilot market interventions across both workstreams, with clear articulation of expected impact on reducing lead exposure.

Pilot Planning & Design

• Develop detailed pilot blueprints for selected interventions: implementation plans, resource requirements, partnerships, budgets, timelines, risk assessments, and mitigation strategies.
• Design outcomes-based measurement & evaluation framework for each pilot: define metrics, data collection plans, monitoring and evaluation (M&E) tools.
• Prepare implementation toolkits and support materials for roll-out (e.g., SOPs, stakeholder engagement plans, supplier/distributor onboarding, regulatory compliance guidance).

Facilitate stakeholder coordination — including with governments, regulators, manufacturers, suppliers, SMEs, NGOs partners — to secure buy-in, partnerships, and support for pilot roll-out.

Additional Responsibilities

• Support donor engagement and proposal development as needed (concept notes, funding proposals, progress reports).
• Provide advisory support to governments, regulatory bodies, or industry associations on regulatory guidance and market shaping strategies.
• Remain updated on global developments in lead exposure, paint regulation, diagnostic technologies, and safer-substitute innovations.

Education & Experience

• Advanced Degree (master’s or equivalent) in a relevant field plus minimum 5 years of work experience.
• Experience in market shaping, supply chain analysis, or commercial strategy — ideally in paints/chemicals, diagnostics, medical devices, or pharmaceutical industries.
• Prior experience working in or with LMICs preferred; familiarity with Indian regulatory and market contexts is an advantage.

Skills

• Strong analytical capabilities (qualitative and quantitative), with ability to absorb and synthesize a broad range of information, including financial, regulatory, pharmaceutical, and scientific information
• Proven ability to conduct primary & secondary research including stakeholder interviews and market assessments.
• Excellent communication skills — ability to prepare high-quality reports, presentations, and briefs for diverse audiences including government, donors, and technical partners.
• High level of proficiency in Excel, PowerPoint, and Word
• Creative thinker enabling development of transformational solutions.
• Entrepreneurial mindset with ability to work independently, self-motivate, and propose innovative ideas.
• Detail-oriented with strong project management instincts.

Travel

• Willingness to travel frequently within India, with potential for occasional international travel for consultations and conferences.

Last Date to Apply: 22 December 2025 (interviews and shortlists are done on first come first serve basis)